# UCLA Clinical Translational Science Institute

> **NIH NIH UL1** · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2021 · $6,271,504

## Abstract

OVERALL
PROJECT SUMMARY/ABSTRACT
The UCLA Clinical and Translational Science Institute is a research partnership of UCLA-Westwood, Cedars-
Sinai Medical Center, Charles R. Drew University of Medicine and Science and the Los Angeles Biomedical
Institute at Harbor-UCLA Medical Center. Its mission is to bring biomedical innovations to bear on the greatest
health needs of Los Angeles—the largest and one of the most ethnically, socially and economically diverse
counties in the United States. In doing so, our goal is to become a leading contributor in the CTSA Consortium
and speed scientific translation to benefit the nation as a whole. The CTSI has five aims: (1) Prepare the
translational workforce to conduct high-quality, multidisciplinary team science; (2) Engage stakeholder
communities in clinical and translational research and disseminate successful models of collaboration;
(3) Integrate special populations, especially those experiencing health disparities, into research; (4)
Improve methods and processes to accelerate scientific translation, overcome key roadblocks and
support multisite research; (5) Provide informatics solutions to operational and scientific roadblocks to
advance high-impact translational science within the UCLA CTSI and the CTSA network. Our novel
infrastructure includes: The Los Angeles Data Resource (LADR), a federation of clinical data warehouses from
six Los Angeles institutions; its governance agreement serves as the model for the CTSA ACT initiative; an
Innovation and Implementation Core with Los Angeles County, a laboratory for testing approaches for improving
care for the nearly 700,000 people annually treated in the county health system; a Precision Medicine program
that forms the infrastructure to bring genomic-level diagnosis to translational investigation and clinical care
across our UCLA Hub, multiple CTSAs and partner institutions; a training program that integrates
entrepreneurship principles in on-the-job training experiences in which investigators are guided to utilize their
own findings as they bring their discoveries to products. We propose to transform our CTSI from a high-
functioning service organization into a well-integrated research accelerator that will develop, demonstrate and
disseminate novel solutions to translational roadblocks, to the ultimate benefit of the Los Angeles community,
our region and the nation.

## Key facts

- **NIH application ID:** 10401701
- **Project number:** 3UL1TR001881-05S2
- **Recipient organization:** UNIVERSITY OF CALIFORNIA LOS ANGELES
- **Principal Investigator:** Steven M. Dubinett
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $6,271,504
- **Award type:** 3
- **Project period:** 2016-07-01 → 2022-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10401701

## Citation

> US National Institutes of Health, RePORTER application 10401701, UCLA Clinical Translational Science Institute (3UL1TR001881-05S2). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10401701. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*